China Health Group Inc. (HKG:8225)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.139
-0.001 (-0.71%)
Mar 3, 2026, 2:36 PM HKT
-17.26%
Market Cap 138.35M
Revenue (ttm) 32.63M
Net Income (ttm) -14.43M
Shares Out 995.35M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 160,000
Average Volume 99,000
Open 0.142
Previous Close 0.140
Day's Range 0.139 - 0.142
52-Week Range 0.131 - 0.198
Beta -0.42
RSI 45.00
Earnings Date Mar 27, 2026

About China Health Group

China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers phar... [Read more]

Sector Healthcare
Founded 1998
Employees 44
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8225
Full Company Profile

Financial Performance

In 2024, China Health Group's revenue was 26.45 million, an increase of 23.47% compared to the previous year's 21.43 million. Losses were -14.52 million, -74.97% less than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.